Preparation of Fe3O4 magnetic nanoparticles coated with gallic acid for drug delivery

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5745-5756

  Dorniani, Dena ^a   Hussein, Mohd Zobir Bin ^a   Kura, Aminu Umar ^a   Fakurazi, Sharida ^a   Shaari, Abdul Halim ^a   Ahmad, Zalinah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Chitosan; Controlled release; Drug delivery; Gallic acid; Magnetic nanoparticles; Superparamagnetic

Indexed keywords

GALLIC ACID; MAGNETIC NANOPARTICLE; MAGNETITE NANOPARTICLE; NANOCOATING;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL VIABILITY; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG HALF LIFE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; NANOPHARMACEUTICS; PARTICLE SIZE; PH MEASUREMENT; THERMOSTABILITY; TIMED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ADSORPTION; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; CRYSTALLIZATION; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; GALLIC ACID; HT29 CELLS; HUMANS; MAGNETITE NANOPARTICLES; MATERIALS TESTING; NANOCAPSULES; PARTICLE SIZE; SONICATION;

EID: 84870307407     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S35746     Document Type: Article

References (49)

1. Plank C, Schillinger U, Scherer F, etal. The magnetofection method: using magnetic force to enhance gene delivery. Biol Chem. 2005;384(5):737-747.
2. Sun Y, Duan L, Guo Z, etal. An improved way to prepare superparamagnetic magnetite-silica core-shell nanoparticles for possible biological application. J Magn Magn Mater. 2005;285(1):65-70.
3. Lu AH, Salabas EL, Schüth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed. 2007; 46(8):1222-1244.
4. Zubarev AY, Iskakova LY. To the theory of rheological properties of ferrofluids: influence of drop-like aggregates. Physica A. 2004;343:65-80.
5. Rossi LM, Silva FP, Vono LLR, etal. Superparamagnetic nanoparticle-supported palladium: a highly stable magnetically recoverable and reusable catalyst for hydrogenation reactions. Green Chem. 2007;9(4):379-385.
6. Lee JH, Jun Y, Yeon SI, Shin JS, Cheon J. Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma. Angew Chem Int Ed Engl. 2006;118(48):8340-8342.
7. Hu FQ, Wei L, Zhou Z, Ran YL, Li Z, Gao MY. Preparation of biocompatible magnetite nanocrystals for in vivo magnetic resonance detection of cancer. Adv Mater. 2006;18(19):2553-2556.
8. Nasongkla N, Bey E, Ren J, etal. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006;6(11):2427-2430.
9. Wu W, He Q, Jiang C. Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res Lett. 2008; 3(11):397-415.
10. Salehizadeh H, Hekmatian E, Sadeghi M, Kennedy K. Synthesis and characterization of core-shell Fe3O4-gold-chitosan nanostructure. J Nanobiotechnol. 2012;10(1):1-7.
11. Park HY, Schadt MJ, Wang L, etal. Fabrication of magnetic core@ shell Fe oxide@ Au nanoparticles for interfacial bioactivity and bio-separation. Langmuir. 2007;23(17):9050-9056.
12. Sonvico F, Mornet S, Vasseur S, etal. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug Chem. 2005;16(5):1181-1188.
13. Zhang J, Misra RDK. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: Core-shell nanoparticle carrier and drug release response. Acta Biomater. 2007;3(6):838-850.
14. Jordan A, Scholz R, Maier-Hauff K, etal. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J Magn Magn Mater. 2001;225(1):118-126.
15. Fortin JP, Wilhelm C, Servais J, Ménager C, Bacri JC, Gazeau F. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J Am Chem Soc. 2007;129(9):2628-2635.
16. Silva AC, Oliveira TR, Mamani JB, etal. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomedicine. 2011;6:591-603.
17. Johannsen M, Gneveckow U, Eckelt L, etal. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia. 2005;21(7):637-647.
18. Basel MT, Balivada S, Wang H, etal. Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. Int J Nanomedicine. 2012;7(1):297-306.
19. Kuznetsov AA, Filippov VI, Alyautdin RN, Torshina NL, Kuznetsov OA. Application of magnetic liposomes for magnetically guided transport of muscle relaxants and anti-cancer photodynamic drugs. J Magn Magn Mater. 2001;225(1):95-100.
20. Kuznetsov AA, Filippov VI, Kuznetsov OA, Gerlivanov VG, Dobrinsky EK, Malashin SI. New ferro-carbon adsorbents for magnetically guided transport of anti-cancer drugs. J Magn Magn Mater. 1999;194(1):22-30.
21. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2):283-318.
22. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci. 2008;101(2):239-253.
23. Avilés MO, Ebner AD, Ritter JA. In vitro study of magnetic particle seeding for implant assisted-magnetic drug targeting. J Magn Magn Mater. 2008;320(21):2640-2646.
24. Zhou H, Yu W, Guo X, etal. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin. Biomacromolecules. 2010;11(12):3480-3486.
25. Gupta AK, Gupta M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials. 2005;26(13):1565-1573.
26. Qu J, Liu G, Wang Y, Hong R. Preparation of Fe3O4-chitosan nanoparticles used for hyperthermia. Adv Powder Technol. 2010;21(4):461-467.
27. Pasanphan W, Chirachanchai S. Conjugation of gallic acid onto chitosan: an approach for green and water-based antioxidant. Carbohydr Polym. 2008;72(1):169-177.
28. Cho YS, Kim SK, Ahn CB, Je JY. Preparation, characterization, and antioxidant properties of gallic acid-grafted-chitosans. Carbohydr Polym. 2011;83(4):1617-1622.
29. Saifuddin N, Dinara S. Immobilization of Saccharomyces cerevisiae onto cross-linked chitosan coated with magnetic nanoparticles for adsorption of uranium (VI) ions. Adv Nat Appl Sci. 2012;6(2):249-267.
30. Feng J, Mao J, Wen X, Tu M. Ultrasonic-assisted in situ synthesis and characterization of superparamagnetic Fe3O4 nanoparticles. J Alloys Compd. 2011;509(37):9093-9097.
31. Andrade ÂL, Souza DM, Pereira MC, Fabris JD, Domingues RZ. pH effect on the synthesis of magnetite nanoparticles by the chemical reduction-precipitation method. Química Nova. 2010;33(3):524-527.
32. Nakayama H, Hatakeyama A, Tsuhako M. Encapsulation of nucleotides and DNA into Mg-Al layered double hydroxide. Int J Pharm. 2010;393(1/2):105-112.
33. Wang Z, Wang E, Gao L, Xu L. Synthesis and properties of Mg2Al layered double hydroxides containing 5-fluorouracil. J Solid State Chem. 2005;178(3):736-741.
34. Xia SJ, Ni ZM, Xu Q, Hu BX, Hu J. Layered double hydroxides as supports for intercalation and sustained release of antihypertensive drugs. J Solid State Chem. 2008;181(10):2610-2619.
35. Hussein MZ, Hashim N, Yahaya AH, Zainal Z. Synthesis and characterization of [4-(2, 4-dichlorophenoxybutyrate)-zinc layered hydroxide] nanohybrid. Solid State Sci. 2010;12(5):770-775.
36. Ribeiro C, Arizaga GGC, Wypych F, Sierakowski MR. Nanocomposites coated with xyloglucan for drug delivery: in vitro studies. Int J Pharm. 2009;367(1/2):204-210.
37. Hussein Al Ali SH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN. Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. Int J Nanomedicine. 2012;7:2129-2141.
38. Hussein Al-Ali SH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN. In vitro inhibition of histamine release behavior of cetirizine intercalated into Zn/Al-and Mg/Al-layered double hydroxides. Int J Mol Sci. 2012;13(5):5899-5916.
39. Hussein Al-Ali SH, Al-Qubaisi M, Hussein MZ, Zainal Z, Hakim MN. Preparation of hippurate-zinc layered hydroxide nanohybrid and its synergistic effect with tamoxifen on HepG2 cell lines. Int J Nanomedicine. 2011;6:3099-3111.
40. Hussein Al-Ali SH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN. Comparative study of Mg/Al-and Zn/Al-layered double hydroxide-perindopril erbumine nanocomposites for inhibition of angiotensin-converting enzyme. Int J Nanomedicine. 2012;7:4251-4262.
41. Hussein Al-Ali SH, Al-Qubaisi M, etal. Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells. Int J Nanomedicine. 2012;7:3351-3363.
42. Zhao Y, Qiu Z, Huang J. Preparation and analysis of magnetic Fe3O4 nanoparticles used as targeted-drug carriers. Chinese J Chem Eng. 2008;16(3):451-455.
43. Nidhin M, Indumathy R, Sreeram KJ, Nair BU. Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates. Bulletin of Materials Science. 2008;31(1):93-96.
44. Ma H, Qi X, Maitani Y, Nagai T. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. Int J Pharm. 2007;333(1):177-186.
45. Ge Y, Zhang Y, Xia J, etal. Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro. Colloid Surf B Biointerfaces. 2009;73(2):294-301.
46. Dong L, Yan L, Hou WG, Liu SJ. Synthesis and release behavior of composites of camptothecin and layered double hydroxide. J Solid State Chem. 2010;183(8):1811-1816.
47. Ho YS, Ofomaja AE. Pseudo-second-order model for lead ion sorption from aqueous solutions onto palm kernel fiber. J Hazard Mater. 2006;129(1):137-142.
48. Fariedi A, Kurnia D, Faried LS, etal. Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff) Boerl, on human cancer cell lines. Int J Oncol. 2007;30(3):605-613.
49. Maurya DK, Nandakumar N, Devasagayam TPA. Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms. J Clin Biochem Nutr. 2011;48(1):85-90.